Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer

World Journal of Urology

Volumn 32, Issue 2, 2014, Pages 399-405

  Cho, Yong Mee ^a   Jung, Soo Jin ^b   Cho, Namhoon ^c   Kim, Min ju ^a   Kattan, Michael W ^d   Yu, Changhong ^d   Ahn, Hanjong ^a   Ro, Jae Y ^e  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d LERNER RESEARCH INSTITUTE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Nomogram; Prostate cancer; Racial variation; Recurrence

Indexed keywords

KALLIKREIN; KALLIKREIN RELATED PEPTIDASE 3, HUMAN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; COHORT ANALYSIS; DISEASE FREE SURVIVAL; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY; SOUTH KOREA; TUMOR RECURRENCE;

AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84897065786     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1111-6     Document Type: Article

References (16)

1. Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61: 1079-1092.
2. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
4. National Cancer Information Center. http://www. cancer. go. kr.
5. Song C, Ro JY, Lee MS et al (2006) Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 68: 820-824.
6. Park SK, Sakoda LC, Kang D et al (2006) Rising prostate cancer rates in South Korea. Prostate 66: 1285-1291.
7. Eble JN, Sauter G, Epstein JI et al (2004) World Health Organization classification of tumors. IARC Press, Lyon.
8. Edge SB, Fritz AG, Byrd DR et al (2010) Cancer staging handbook from the AJCC cancer staging manual, 7th edn. Verlag, New York, pp 547-560.
9. Stephenson AJ, Scardino PT, Eastham JA et al (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23: 7005-7012.
10. Amin MB, Grignon D, Bostwick D et al (1996) Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 105: 667-670.
11. Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56: 337-344.
12. Song X, Ma S, Huang J et al (2007) A semiparametric approach for the nonparametric transformation survival model with multiple covariates. Biostatistics 8: 197-211.
13. Stephenson AJ, Kattan MW, Eastham JA et al (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24: 3973-3978.
14. Hsu YS, Wang JS, Wu TT (2004) E-cadherin expression in prostate adenocarcinomas in Chinese and its pathological correlates. Urol Int 73: 36-40.
15. Egawa S, Suyama K, Arai Y et al (2001) Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol 8: 295-300.
16. Shariat SF, Karakiewicz PI, Roehrborn CG et al (2008) An updated catalog of prostate cancer predictive tools. Cancer 113: 3075-3099.